Enhertu approved in the EU as the first tumor-agnostic HER2-targeted ADC for previously treated HER2...

Datroway recommended for approval in the EU as 1st-line treatment for patients with metastatic TNBC...

SYS6043 granted BTD in China for the treatment of platinum-resistant Ovarian cancer

FDA alignment to advance ProstACT Global phase 3 trial

Glenmark advances phase 3 trial of Trastuzumab rezetecan in platinum-resistant Ovarian cancer

CSPC initiates phase 3 trial of SYS-6010 in combination with Enlonstobart in resected stage II–IIIB...